Filter results
06/11/2025
ROVI ACHIEVED OPERATING REVENUE OF 525.1 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 3.5 PERCENTAGE POINTS
21/10/2025
The Swiss company has placed its confidence in ROVI for the manufacture of this product for its global launch
24/07/2025
ROVI ACHIEVED OPERATING REVENUE OF 314.6 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 3.0 PERCENTAGE POINTS
10/07/2025
Final Decision to award aid of 36.3 million euros for ROVI’s LAISOLID project subsidised by the CDTI
The beneficiary project, LAISOLID, focuses on developing new sterile filling technologies for polymeric matrices and new methodologies to accelerate the development of medicines based on predictive models
18/06/2025
ROVI distributes dividends of 48 million euros and approves all the items on the agenda at its General Shareholders’ Meeting by a wide margin
08/05/2025
The beneficiary project, LAISOLID, focuses on developing new sterile filling technologies for polymeric matrices and new methodologies to accelerate the development of medicines based on predictive models
08/05/2025
ROVI ACHIEVED EBITDA GROWTH OF 17%